跳至主要内容
临床试验/IRCT20240411061470N2
IRCT20240411061470N2已完成Unknown

The effect of supplementation with type I and type III collagen peptide and type II hydrolysed collagen on pain, quality of life and physical function in patients with meniscopathy: a randomised, double-blind, placebo-controlled study

Ondokuz Mayis University0 个研究点目标入组 35 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 65 years(—)
性别
All

入选标准

  • Diagnosis of unilateral or bilateral grade 1 or 2 meniscal tear for more than 3 months
  • No history of any serious acute trauma to the knee
  • No X-ray or MRI evidence of osteoarthritis
  • Non-vegetarian
  • Willingness to participate in all visits and tests foreseen for the study

排除标准

  • Any history of trauma, fracture or surgery on the index joint
  • Evidence or history of clinically significant hematologic, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, neurologic diseases or malignancies within the last 5 years
  • Active viral or bacterial infection according to clinical examination
  • Knee surgery within the last 12 months or planned surgery within the working period
  • Intra-articular injections (cortisol, hyaluronic acid, etc.) within the last 6 months
  • Taking supplements such as hydrolyzed collagen, glucosamine or chondroitin in the last 6 months
  • Intolerance to protein-based foods or supplements, pregnant or breastfeeding, and alcohol dependence

研究者

相似试验